Omiics ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  7.9% 8.2% 10.5% 8.0% 31.5%  
Credit score (0-100)  31 28 22 29 1  
Credit rating  BB BB BB BB C  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  1,202 1,615 2,476 2,365 2,395  
EBITDA  146 150 175 11.1 -600  
EBIT  146 137 160 -3.5 -602  
Pre-tax profit (PTP)  117.0 173.6 50.7 53.3 -588.4  
Net earnings  89.9 135.9 39.0 40.1 -588.4  
Pre-tax profit without non-rec. items  117 174 50.7 53.3 -588  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 31.1 16.5 1.9 0.0  
Shareholders equity total  388 424 463 503 -135  
Interest-bearing liabilities  1.2 18.2 0.0 0.0 3.1  
Balance sheet total (assets)  762 1,757 1,711 1,391 862  

Net Debt  -233 -724 -1,271 -751 -150  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,202 1,615 2,476 2,365 2,395  
Gross profit growth  -11.3% 34.4% 53.3% -4.5% 1.3%  
Employees  2 2 4 4 5  
Employee growth %  0.0% 0.0% 100.0% 0.0% 25.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  762 1,757 1,711 1,391 862  
Balance sheet change%  15.0% 130.6% -2.6% -18.7% -38.1%  
Added value  145.5 150.0 174.9 11.1 -600.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 18 -29 -29 -4  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 -1.0 -2.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  12.1% 8.5% 6.5% -0.1% -25.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  21.9% 15.3% 11.1% 3.7% -47.6%  
ROI %  44.2% 46.2% 42.6% 11.9% -224.4%  
ROE %  26.2% 33.5% 8.8% 8.3% -86.2%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  50.9% 24.1% 27.1% 36.2% -13.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -160.1% -482.6% -726.6% -6,752.5% 25.0%  
Gearing %  0.3% 4.3% 0.0% 0.0% -2.3%  
Net interest  0 0 0 0 0  
Financing costs %  3,402.0% 196.0% 1,557.6% 0.0% 1,314.9%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.7 1.3 1.3 1.5 0.7  
Current Ratio  2.0 1.3 1.3 1.5 0.8  
Cash and cash equivalent  234.3 742.1 1,271.2 750.6 153.4  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  369.4 -281.4 -109.3 -115.9 -166.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  73 75 44 3 -120  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  73 75 44 3 -120  
EBIT / employee  73 69 40 -1 -120  
Net earnings / employee  45 68 10 10 -118